Emma Brown

Emma Brown

Auto-generated profile, based on publicly available information

Emma Brown

Department of Transmission Biology, The Pirbright Institute, Woking, United Kingdom

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Preventive Veterinary Medicine
Verified
Journal Article
Closed access
EBEmma Brown
Emma Brown
AMAdele H. Marshall
Adele H. Marshall
HMHannah J. Mitchell
Hannah J. Mitchell
Andrew ByrneAndrew Byrne
Andrew Byrne

15 August 2018 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
PDF file
CCClaire Colenutt
Claire Colenutt
EBEmma Brown
Emma Brown
NNNoel Nelson
Noel Nelson
JWJemma Wadsworth
Jemma Wadsworth
JMJenny Maud
Jenny Maud
SGSimon Gubbins
Simon Gubbins
Prompt confirmation and diagnosis of disease are key factors in controlling outbreaks. The development of sampling techniques to detect FMDV RNA from the environment will extend the tool kit available for the surveillance of this pathogen. The methods presented in this article broaden surveillance opportunities using accessible techniques. Pairing these methods with existing and novel diagnostic tests will improve the capability for rapid detection of outbreaks and implementation of timely interventions to control outbreaks. In areas of endemicity, these methods can be implemented to extend surveillance beyond the investigation of clinical cases, providing additional data for the assessment of virus circulation in specific areas.

17 May 2021 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
EBEmma Brown
Emma Brown
GFgraham freimanis
graham freimanis
ASAndrew Shaw
Andrew Shaw
DHDaniel L. Horton
Daniel L. Horton
SGSimon Gubbins
Simon Gubbins
DKDavid King
David King
The sequencing of viral genomes provides important data for the prevention and control of foot-and-mouth disease (FMD) outbreaks. Sequence data can be used for strain identification, outbreak tracing, and aiding the selection of the most appropriate vaccine for the circulating strains. At present, sequencing of FMD virus (FMDV) relies upon the time-consuming transport of samples to well-resourced laboratories. The Oxford Nanopore Technologies' MinION portable sequencer has the potential to allow sequencing in remote, decentralised laboratories closer to the outbreak location. In this study, we investigated the utility of the MinION to generate sequence data of sufficient quantity and quality for the characterisation of FMDV serotypes O, A, Asia 1. Prior to sequencing, a universal two-step RT-PCR was used to amplify parts of the 5′UTR, as well as the leader, capsid and parts of the 2A encoding regions of FMDV RNA extracted from three sample matrices: cell culture supernatant, tongue epithelial suspension and oral swabs. The resulting consensus sequences were compared with reference sequences generated on the Illumina MiSeq platform. Consensus sequences with an accuracy of 100% were achieved within 10 and 30 min from the start of the sequencing run when using RNA extracted from cell culture supernatants and tongue epithelial suspensions, respectively. In contrast, sequencing from swabs required up to 2.5 h. Together these results demonstrated that the MinION sequencer can be used to accurately and rapidly characterise serotypes A, O, and Asia 1 of FMDV using amplicons amplified from a variety of different sample matrices.